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ARTICLE
A cell ﬁtness selection model for neuronal survival
during development
Yiqiao Wang 1,11, Haohao Wu1,11, Paula Fontanet1, Simone Codeluppi2, Natalia Akkuratova3, Charles Petitpré1,
Yongtao Xue-Franzén1, Karen Niederreither4, Anil Sharma 1, Fabio Da Silva5, Glenda Comai 6,
Gulistan Agirman1, Domenico Palumberi1, Sten Linnarsson 2, Igor Adameyko3,7, Aziz Moqrich8,
Andreas Schedl5, Gioele La Manno9, Saida Hadjab1,12 & François Lallemend1,10,12
Developmental cell death plays an important role in the construction of functional neural
circuits. In vertebrates, the canonical view proposes a selection of the surviving neurons
through stochastic competition for target-derived neurotrophic signals, implying an equal
potential for neurons to compete. Here we show an alternative cell ﬁtness selection of
neurons that is deﬁned by a speciﬁc neuronal heterogeneity code. Proprioceptive sensory
neurons that will undergo cell death and those that will survive exhibit different molecular
signatures that are regulated by retinoic acid and transcription factors, and are independent
of the target and neurotrophins. These molecular features are genetically encoded, repre-
senting two distinct subgroups of neurons with contrasted functional maturation states and
survival outcome. Thus, in this model, a heterogeneous code of intrinsic cell ﬁtness in
neighboring neurons provides differential competitive advantage resulting in the selection of
cells with higher capacity to survive and functionally integrate into neural networks.
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Programmed cell death plays a fundamental role in animaldevelopment and tissue homeostasis. In the mammaliannervous system, massive cell death and axonal degeneration
represent an essential process in the formation of functional
neural circuits during development1,2. The accepted mechanism
driving the death of neurons during this critical period involves a
stochastic competition between neurons for limiting access to
target-derived neurotrophic factors3,4. Yet, how or which given
cells are chosen to survive or die is still poorly understood.
In the vertebrate nervous system, the majority of neurons form
during embryonic development when, after a phase of neuro-
genesis, a vast number of them are quickly removed by apoptosis
in order to optimize quantitatively the connectivity between
neurons and their targets (systems matching) and control the
ﬁnal architecture of the neuronal structures1,3,4. In the peripheral
nervous system, survival of selected neurons depends on target-
derived neurotrophins (NTs)5,6, which bind to speciﬁc tropo-
myosin receptor kinase (TRK) receptors on the neuronal cell
surface7. Typically, the binding of TRK receptors by their cognate
NTs at the nerve endings induces a retrograde transport signaling
that supports the survival, growth and differentiation of the
neurons8,9. The neurotrophic theory is the prevailing model for
the regulation of neuronal cell death during development3,4. This
model proposes that neurons produced in excess compete for a
limited supply of NTs synthesized in their target ﬁelds4,10–12.
Built into this model is also the assumption that the probability of
individual neurons to survive the competition for NTs cannot be
predicted10,13,14, implying that all neurons are endowed with an
equal potential to compete. However, very early on, neurons
exhibit intrinsic differences that control their differentiation and
axon targeting15–17, emphasizing the need to re-examine the
stochastic nature of the neurotrophic theory and to determine
whether cell-to-cell molecular variability and survival predict-
ability represent strong selection mechanisms during neuronal
competition for NTs-induced survival (Fig. 1a). In this context, a
more deterministic life-or-death regulation, coupled with these
intrinsic differentiation mechanisms, would provide a way for
selecting the ﬁttest cells during development.
Here, we tested this hypothesis using tropomyosin receptor
kinase C (TRKC)+ proprioceptive sensory neurons (PSNs) of the
dorsal root ganglia (DRG) and demonstrate that the survival
probability is not equal amongst neurons and hence some neu-
rons are more likely to die. We show that before cell death period
starts, the presumptive PSNs display different molecular blue-
prints initiated by the morphogen retinoic acid (RA) and which
lead through transcriptional regulation to distinct subgroups of
neurons with different functional ﬁtness and survival outcome.
Thus, our data demonstrate a predisposition to cell death during
development, where molecular ﬁtness heterogeneity in sensory
neurons predicts their survival probability and the selection of the
ﬁttest cells for the establishment of functional neural networks.
Results
Heterogeneity of TRKC expression in PSNs before cell death.
To investigate whether neurons are equivalent prior to the cell
death period, we used the DRG that have been extensively studied
for neuronal cell death regulation during development. We
focused on the development of the PSNs, which later innervate
skeletal muscles and represent a major neuronal population of the
DRG of the trunk18. During embryogenesis, PSNs are char-
acterized by the expression of the transcription factors RUNX3
and of TRKC, the speciﬁc receptor for neurotrophin-3 (NT3)
(Fig. 1b)17–19. At embryonic day (E) 11.5, most TRKC+ DRG
neurons at brachial levels are RUNX3+ (and all RUNX3+ neu-
rons are TRKC+), the vast majority of them being actual PSNs, as
assessed by genetic tracing of TRKC-expressing neurons from
E11.5 to E17.5 using TrkCCreER;R26tdTOM mice (Fig. 1c and
Supplementary Fig. 1)18,20–22. On the other hand, NT3 is syn-
thetized in the mesenchyme and the early muscle mass sur-
rounding the growing axons of TRKC+ PSNs during
development23. Upon binding to TRKC, NT3 retrogradely acti-
vates pro-survival signaling events that are required for PSNs to
survive the cell death period, which occurs from E12.0 to E12.5
and before target innervation (Fig. 1d)24–26.
The classic neurotrophic hypothesis considers that neurons
have equal capacity to compete and thus, to survive the
developmental cell death period, implying similarity in their
molecular features before they reach their target13,14. However, at
E11.0–11.5, analysis of the molecular identity of PSNs showed a
high variability in their TRKC expression, with no obvious spatial
pattern or a correlation with the cell size (Fig. 1e–i and
Supplementary Fig. 2). This heterogeneity was maintained
in vitro, with TRKC levels correlating between the soma and
nerve endings where NT3 engages its receptor in vivo (Supple-
mentary Fig. 3). The functional, full length (FL) tyrosine kinase
isoform of Ntrk37 was the predominant isoform (64.34 ± 1.03%)
in E11.5 brachial DRG when analyzed by real-time quantitative
polymerase chain reaction (PCR), and results from immunos-
tainings and single-molecule RNA ﬂuorescence in situ hybridiza-
tion (smFISH) conﬁrmed the high cell-to-cell variable expression
of the Ntrk3 FL isoform (Fig. 1j, k and Supplementary Fig. 4).
Thus, our results clearly indicate that prior to cell death period,
TRKC FL expression in individual PSNs is highly heterogeneous.
To examine whether the different levels of TRKC in PSNs arise
from protein accumulation during neurogenesis (from E9.5 to
E10.5 in mice)27, with the early born neurons having accumulated
more protein over time than later born counterparts, we fate-
mapped early born TRKC neurons. For this, we induced
recombination in TrkCCreER;R26tdTOM mice at ~E9.75 with a
single injection of 4-hydroxytamoxifen (4-OHT, 0.06 g/kg).
Convincingly, recombination in PSNs was not correlated with
their TRKC levels observed at E11.5 as tdTomato (TOM)+ cells
analyzed at this stage were similarly distributed among the
TRKCHigh and TRKCLow categories of PSNs (Fig. 1l–n), indicat-
ing that TRKC heterogeneity is independent of birthdate.
TRKC levels are associated with competitive advantage. The
high variability of TRKC levels among PSNs at early develop-
mental stages suggests a target-independent control of their
molecular heterogeneity. Here, we explored the possible inﬂuence
of the environment on TRKC levels, focusing on NT3, which is
expressed around the projecting axons in the limb23. Using real-
time quantitative PCR and immunohistochemistry, we showed
that TRKC expression is completely independent of NT3 both
in vitro and in vivo (Fig. 2a–c); Etv1 expression, known to depend
on NT3 in vivo28, showed, however, a 4.4-fold increase in NT3
condition (P < 0.001, unpaired Student’s t-test). In line with that
hypothesis, a previous work in embryonic chicken DRG showed
that ablation of the limb does not alter TRKC expression in the
corresponding DRG neurons prior to cell death, indicating that
TRKC levels in PSNs are established independently of target-
derived signals17. To study the transcriptional control of TRKC
levels, we focused on the transcription factor RUNX3, which is
known to transactivate the Ntrk3 locus29 (Ntrk3 codes for TRKC),
and showed a tight correlation with TRKC levels in E11.5 PSNs
(Fig. 2d). Analysis of Runx3−/− mice at E11.5 showed sig-
niﬁcantly lower levels of TRKC in PSNs (now similar to the
TRKCLow category in Ctr animals), with however similar number
of neurons (Fig. 2e, f). This conﬁrmed earlier studies on the role
of RUNX3 on TRKC levels but not on its induction17,19. In
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contrast, RUNX3 levels remained unchanged up to E12.5 in the
absence of NT3-TRKC signaling (Supplementary Fig. 5), con-
ﬁrming that NT3 does not induce or regulate RUNX3 expres-
sion19. Collectively, our data support a model in which the
variable levels of TRKC expression in PSNs are intrinsically
regulated prior to cell death period in a target- and NT-
independent manner.
Given the essential role of TRKC signaling in the survival of
developing PSNs, we sought to analyze the possible relationship
between TRKC levels in PSNs and their survival capacity. We
found a positive correlation between the levels of TrkC and the
expression of the phosphorylated form of the serine/threonine-
speciﬁc protein kinase AKT, which acts within the TRKC
signaling survival pathway during the cell death period7 (Fig. 2g),
suggesting more survival advantage for neurons with high relative
TRKC levels. For our hypothesis to hold, lower TRKC-expressing
PSNs would be more vulnerable to limited amount of NT3. We
thus tested whether the levels of TRKC in PSNs impact their
responsiveness to NT3 and hence their survival capacity. We took
advantage of Runx3−/− mice, which have very low levels of
TRKC in PSNs and in which all PSNs die at E12.5 (Fig. 2e, f)17,30.
We challenged PSNs from Runx3−/− DRG in vitro with different
concentrations of NT3. Compared to wild-type neurons, PSNs
from Runx3−/− mice did not respond to NT3-dependent survival
at low concentration (1 ng/ml, EC50, Supplementary Fig. 6b)
while a saturating concentration of NT3 (50 ng/ml) could
promote survival, although to a lesser extent than in wild-type
(Fig. 2h). This indicates that in the Runx3−/− animals (with low
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by 4-OHT induction. TrkCCreER mice allow temporary activation of CreER in the TRKC+ cells 2 h after 4-OHT injection21,22. Immunostaining for PV, RFP and
RUNX3 on E17.5 DRG sections (c) and graph showing distribution of PV+/RUNX3+ PSNs among the TOM+ cells (n= 4). Scale bar: 20 μm.
d Quantiﬁcation of PSNs at C5 and C7. ***P < 0.001, one-way analysis of variance (ANOVA) with Sidak’s multiple comparisons test (n= 2–3). The window
of PSNs cell death is shown. e TRKC expression in E11.5 ISL1+ (and RUNX3+, whose staining is not shown for more visibility) DRG neurons. Scale bar:
50 μm. f TRKC levels in PSNs of e illustrated by color coding; dark blue indicates the lower and red the higher TRKC levels. From here, all observations are
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in (1) and (2) (images show full projection); right panel shows color coding of Ntrk3 FL levels in red; the brighter, the higher levels. k Distribution of the
number of Ntrk3 FL molecules in E11.5 DRG neurons by smFISH, normalized to pan Ntrk3 (Ntrk3 FL represent 68% of all Ntrk3 transcripts). l TrkCCreER;
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TRKC levels in PSNs), the NT3-TRKC survival signaling is still
responsive but only to high concentrations of NT3. To further
support a role for TRKC levels in predisposition of neurons to
apoptosis during competition for NTs, we set out to reduce but
not abolish the level of TRKC in PSNs by electroporating chick
embryos at Hamburger and Hamilton stage 13 (HHst13; before
neural crest migration, around E2) with siRNA either directed
against Ntrk3 and a GFP plasmid (Ntrk3 siRNA) or with a
negative control siRNA and GFP plasmid (Ctr siRNA) (Fig. 2i).
This strategy allows fate tracing of neural crest-derived Ntrk3
siRNA-expressing PSNs, which exhibit low levels of TRKC
(Fig. 2j). It also enables the targeting of only a small proportion of
the neurons (~7% of PSNs), hence avoiding possible indirect role
on neurogenesis as previously shown in mice and chicken
embryos in the absence of NT3-TRKC signaling23,31,32. Analysis
of DRG sections at HHst26/27 (E5), i.e. before the cell death
period of PSNs33, revealed no noticeable loss of GFP+ PSNs in
Ntrk3 siRNA condition (Fig. 2k). In contrast, at HHst30/31, after
the cell death period of PSNs, there was an 80% decrease in the
number of GFP+ PSNs electroporated with Ntrk3 siRNA, when
compared with DRG sections from embryos transfected with
Ctr siRNA (Fig. 2l). This suggests that low TRKC-expressing
PSNs are less ﬁtted to compete for NTs during the cell death
period and predict a greater survival of neurons with higher
TRKC levels. Inhibition of survival competition by means of cell
death blockade using Bax−/− mice (in which all sensory
neurons survive)34 should then prevent this selection and
result in a proportional increase of neurons with low TRKC. In
Bax−/− DRG, the number of PSNs at E13.5 is about 2.2-fold
higher (TRKC+/RUNX3+ neurons from C5–C8; wild-type (WT):
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100 ± 13.7, Bax−/−: 228 ± 12.6.% of WT), reﬂecting a rate of cell
survival that approximates 50% in wild-type PSNs. Consistent
with our prediction, this increase was accompanied by an
overrepresentation of neurons with low TRKC expression
(Fig. 2m, n), a large proportion of them being atrophied
(Supplementary Fig. 6c), suggesting that prevention of natural
PSNs cell death results in the accumulation of neurons with
relative lower TRKC content, which would have been eliminated
in a wild-type context. Together, these data indicate a strong,
positive relationship between TRKC levels, trophic signaling state
and the capacity to compete and survive.
Differential survival of PSN subpopulations in vivo. To directly
assess the higher survival probability of PSNs with high TRKC
levels in vivo, we developed a Cre recombinase-dependent
methodology to genetically trace PSNs as a function of TRKC
expression. Indeed, by using the CreER driver and a low dose of
4-OHT, the fraction of cells undergoing recombination should
depend on the amount of Cre recombinase they express35. To test
this in vivo, we induced limited recombination in TrkCCreER;
R26tdTOM mice at E11.0 with a single injection of 4-OHT
(0.018 g/kg) and analyzed the traced cells before (E11.5) and after
the cell death period (E13.5) (Fig. 3a). At E11.5, recombination
was observed in 11% of PSNs, predominantly labeling neurons
with high TRKC levels (with 75% of TOM+ PSNs expressing
levels of TRKC above the average) (Fig. 3b–d), supporting our
strategy to increase the probability of tracing high TRKC+/high
Cre+ neurons by limiting the Cre activity. Importantly, this
preferential tracing of the high TRKC neurons also demonstrate
that the difference in TRKC levels in PSNs is relatively stable
during this time period. Strikingly, when assessing the survival of
the labeled PSNs after the cell death period (E13.5), we found an
1.88-fold increase in the proportion of labeled PSNs (from 11.6%
at E11.5 to 20.9% at E13.5; Fig. 3e, f), conﬁrming our prediction
and supporting our hypothesis. In sharp contrast, injection of
TrkCCreER;R26tdTOM mice at E14.0 (after the cell death period of
PSNs) with a similar dose of 4-OHT led to an identical propor-
tion of recombined PSNs at both E14.5 (13.2%) and E16.5
(13.5%) (Fig. 3g). Moreover, similar experiments using an
R26CreERT2 driver line, which labels PSNs independently of their
TRKC levels, did not show any enrichment in the proportion of
recombined PSNs (TOM+ amongst TRKC+/RUNX3+ neurons)
between E11.5 and E13.5 (Fig. 3g and Supplementary Fig. 7).
Altogether, our data demonstrate that neuronal competition
selects for neurons with higher TRKC levels during development.
Since NT3 expression in the limb does not seem limited to
particular sub-regions of PSNs targets at E11.523, it is highly
unlikely that this selection mechanism could reﬂect the possibility
that PSNs with differential levels of TRKC would project
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peripherally to distinct target ﬁelds, with distinct availability to
NTs. In support of this, defasciculation of sensory projections
within the limb in mutant mice for axon guidance molecules has
no impact on the neuronal cell death process36,37, and peripheral
projections of PSNs with high TRKC levels did not show any
preference of spatial distribution within peripheral nerves (Fig. 3h,
i). Altogether, this strongly suggests a selection model in which
neighboring neurons with differential ﬁtness compete for NTs in
the target tissue, resulting in the elimination of cells with lower
advantage to compete and survive (Fig. 3j).
Cell ﬁtness characters of PSN subpopulations. Our ﬁndings of
the survival selection of one PSNs group (expressing high levels of
TRKC and of RUNX3) over the other group suggest that these
two groups might represent two genetically distinct PSNs
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subgroups. To test this hypothesis, a total of 350 TOM+ cells
from TrkCCre;R26TOM E11.5 DRG, in which the majority of the
neurons generated between E9.5 and E10.5 are traced38, were
processed for single-cell transcriptome analysis (Fig. 4a). The cell
expression data from Ntrk3+/Runx3+ PSNs were clustered using
R package SEURAT and visualized using bi-dimensional t-dis-
tributed stochastic neighbor embedding (t-SNE) (Fig. 4b, c).
Interestingly, two clusters of PSNs were identiﬁed unbiasedly, and
were associated with distinct levels of Runx3: a Runx3High group
and a Runx3Low group (Fig. 4b–e and Supplementary Data 1). It
is important to note that both subgroups are PSNs since their
genetic tracing at E11.5 lead at E17.5 to 95% of labeled cells with a
PSN phenotype (Fig. 1c and Supplementary Fig. 1) and also
because they all can develop into PSNs when NT3 is over-
expressed in developing muscles39. These two PSNs subgroups
were further distinguished based on their differential expression
of marker genes (Fig. 4d). Runx3High group was characterized by
the expression of Hmx1, Fyxd7, Fam19a4 and an enrichment in
Ntrk3 while the Runx3Low group expressed Sst, Pou2f2 and Tbx3
(Fig. 4d, h). The correlation between Runx3 mRNA level and
TRKC protein, and between TRKC protein and Ntrk3 mRNA,
was then validated in vivo (Fig. 4f, g), as well as the existence of
the two PSNs subgroups (Fig. 4h–k). Our results thus conﬁrmed
the existence of two PSNs subgroups based on their gene
expression and that may correspond to the two PSNs groups with
distinct survival outcome (Fig. 4l). We explored further our
dataset and performed a gene ontology analysis to reveal
benchmark biological categories behind the genetic blueprint of
the Runx3High and Runx3Low. The top signiﬁcant categories
shared by both subgroups were biological categories associated
with neuron development, axogenesis and neuron projection
(Fig. 5a–c and Supplementary Fig. 8a). The two subgroups also
showed similar levels of expression of genes involved in energy/
metabolism (Supplementary Fig. 8b). Though, the two subgroups
were embodied by distinct categories that underlined their tran-
scriptome differences (Fig. 5d). Thus, the Runx3High group
showed enrichment in neurotransmission and synaptic signaling
categories (Fig. 5d, e), which could underlie a higher maturation
of the functional properties of this subgroup. Notably, the levels
of expression of the voltage-gated sodium channels Scn3b
(Navβ3), Scn7a (Nax) and Scn9a (Nav1.7), which contribute to the
generation of a mature action potential40, and of Piezo2, the main
mechanotransduction channels in non-noxious mechanosensitive
sensory neurons41,42, were much higher in the Runx3High sub-
group (Fig. 5f). To visualize the direction of developmental
change within our population of cells, we applied RNA velocity to
our single-cell measurements (PSNs from E11.5 and E12.5) to
predict transcriptional dynamics and the cell state trajectory of
our neurons43. We found similar clustering at E11.5, with the
Runx3Low to the Runx3High subgroups, but only one homo-
geneous cluster of PSNs at E12.5. The RNA velocity analysis
showed a strong directional ﬂow from the Runx3Low to the
Runx3High subgroups and then to the E12.5 stage (Fig. 5h–k),
conﬁrming that the subgroups of PSNs observed at E11.5
represent neurons of various cell states along their maturation
trajectory. In support, marker genes of Runx3Low are not found in
E12.5 PSNs, conﬁrming also our genetic tracing data in Fig. 3
indicating that competition selects for TRKCHigh/RUNX3High
PSNs, the other population being eliminated.
Altogether, those results reveal an unexpected genetic varia-
bility amongst developing PSNs that distinguishes two main
subgroups prior to the cell death period (Fig. 5g). They also
suggest that these transcriptomic differences could represent the
genetic substrates deﬁning both the survival potential of
individual neurons during competition with neighboring cells
and their functional, maturation states before the neurons acquire
transduction competence40.
RA controls RUNX3 expression in PSNs. The postmitotic
induction of RUNX3 in PSNs prompted us to examine the
potential extrinsic signaling pathways regulating RUNX3
expression in presumptive PSNs before the cell death period.
Interestingly, the RA-synthetizing enzyme RALDH2 is found
expressed around the nascent DRG during the early phase of
DRG neuron generation (E9.5–E10.0) and precedes the appear-
ance of RUNX3/TRKC PSNs observed at E10.5 (ref. 44). To deﬁne
the contribution of RA signaling to PSNs differentiation, we ﬁrst
used chicken DRG, which can clearly be distinguished and dis-
sected at the early stages of DRG formation. Similar to mouse,
RALDH2 enzyme was expressed in the mesenchyme surrounding
the nascent DRG following a dorso-ventral gradient and in the
motor neurons (MNs) area of HHst23 chicken embryos (Fig. 6a),
before RUNX3 induction17,45,46. HHst23 DRG explants cultured
for 12 h did not express RUNX3 (Fig. 6b, Ctr), even in the pre-
sence of NT3 (data similar to Ctr), while in contrast, all-trans RA
induced RUNX3 expression in ISL1+ neurons (Fig. 6b, RA).
Interestingly, increasing concentration of RA increased the levels
of RUNX3 expression per individual cells (Fig. 6c). Thus, these
results show that RA can induce a dose-dependent expression of
RUNX3.
To study the role of RA on Runx3 expression in PSNs in vivo,
we used Raldh2−/− embryos treated by a short maternal RA
administration (E7–E9) to allow fetal development47, creating
thus an RA deﬁciency before RUNX3 onset. In line with the
in vitro results, a signiﬁcant proportion of TRKC+ neurons failed
Fig. 4 Single-cell RNA-seq identiﬁes two molecularly distinct populations of PSNs prior to cell death period. a Workﬂow for single-cell RNA-seq (scRNA-
seq) processing of DRG neurons. b Heat map showing single-cell expression of the top 20 differentially expressed genes in the different clusters of DRG
neurons, identifying Clusters 1 and 2 as PSNs. c t-SNE plot showing two distinct populations of Ntrk3+/Runx3+ PSNs at E11.5, the Clusters 1 and 2 in
b. eTRKA: early TRKA neurons; MR: mechanoreceptive neurons18; both populations transiently express TRKC at an earlier time point38. d List of Cluster 1-
(top panel) and Cluster 2-enriched (bottom) genes. e The two clusters express similar levels of classic neuronal markers but differ in their level of Runx3
and Ntrk3 transcripts and are named Runx3High and Runx3Low. Box plots visualize the summary of the dataset (minimum, lower quartile, median, upper
quartile and maximum). Wilcoxon rank sum test (# indicates signiﬁcant difference, see Methods section for details). f, g In vivo validation of the
correlation between TRKC protein and Runx3 mRNA (f) and between TRKC protein and Ntrk3 mRNA (g). **P < 0.01, unpaired Student’s t-test (n= 3).
h–j Marker genes of the Runx3Low and Runx3High subgroups of PSNs; t-SNE plots (h) and in vivo validation by immunostaining or in situ hybridization (i).
Graphs in i show quantiﬁcation of the expression of marker genes for Runx3High (High) and Runx3Low (Low) PSNs (n= 3 animals for each experiment),
expressed in average number of dots for transcripts and average immunostaining intensity for proteins (and normalized to the maximum average value).
***P < 0.001, unpaired Student’s t-test. Scale bar: 5 μm. j In situ hybridization on E11.5 DRG sections showing the (almost) mutually exclusive expression of
Fxyd7 and Pou2f2. Scale bar: 15 μm. k Quantitative illustration of j, where for each TrkC+ neurons, their level of Fxyd7 and Pou2f2 is represented. l Schematic
representation of neuronal types with their key markers and their average soma size (in square micrometers). Source data are available as a Source
Data ﬁle
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Fig. 5 Single-cell data identiﬁes contrasted genetic signatures of neuronal maturation amongst PSNs subpopulations. a t-SNE plots representing the two
groups of PSNs at E11.5 described in Fig. 4. b, c Gene set enrichment analysis of Runx3High and Runx3Low neurons visualized by network. Each node
represents a GO term, edges are drawn when there are shared genes between two GO terms. Interestingly, the neurotransmission category is highly
represented in the Runx3High population while apoptosis and DNA-binding are more represented in the Runx3Low population. c Gene ontology analysis of the
Runx3High (top panel) and Runx3Low (bottom panel). The graph shows most signiﬁcant terms reﬂecting neuronal features. d Examples of differentially
expressed genes found in Runx3High or Runx3Low subpopulations of PSNs. e Expression of select genes that encode proteins relevant to neuronal physiology
(asterisks depict genes important for the generation of action potentials). Note that this category of genes is uniquely over-represented in Runx3High PSNs.
f Expression of genes important for the generation a mature action potentials (Scn3b/7a/9a) and for mechanotransduction in PSNs (see text for details).
Boxplots visualize the summary of the dataset (minimum, lower quartile, median, upper quartile and maximum). g Summary of the differential expression
proﬁle of the two subpopulations of PSNs, with a majority of genes (17,352 genes) showing similar patterns; genes enriched in Runx3High PSNs encode
proteins associated with synaptic communication. h UMAP plot of PSNs single cells RNA-seq data from E11.5 and E12.5 (before and after cell death period,
respectively), revealing two clusters at E11.5 (blue and red, corresponding to the clusters in a) and only one cluster at E12.5 (green). i Expression pattern
using UMAP plots with speciﬁc Runx3High and Runx3Low marker genes shows that marker genes of E11.5 Runx3High remain expressed at E12.5.
j Unspliced–spliced phase portraits (left, cells colored according to a) and u residuals (right) are shown for each gene in i. k Velocity estimates projected
onto the two-dimensional UMAP plot of the dataset shown in h, and with a similar color code. Velocity vectors indicate positive velocity (strong directional
ﬂow) from one cell state to another and overall can be interpreted as a maturation directionality from Cluster 1 to Cluster 3. Source data are available as a
Source Data ﬁle
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to induce RUNX3 expression in Raldh2−/− mice (29%, n= 4,
P= 0.005, t-test, Fig. 6d, f), while the total number of neurons
and TRKC+ cells remained unchanged (Fig. 6e). Consistent with
the role of RUNX3 on TRKC levels, presumptive PSNs that failed
to acquire RUNX3 expression in Raldh2−/− mice showed a
signiﬁcantly lower expression of TRKC per cell than PSNs in
Raldh2+/+ mice (Fig. 6d, g). Notably, analysis of Raldh2−/− mice
after the cell death period (E12.5) showed an almost twofold
decrease in the number of PSNs compared to Raldh2+/+ mice
(Fig. 6h). To prevent possible compensatory mechanisms for the
loss of RALDH2 by ectopic expression of RALDH1 and
RALDH3, we used a mutant mouse model in which the three
members of the Raldh family are deleted conditionally:
CAGGCreER;Raldh1ﬂ/ﬂ;Raldh2ﬂ/ﬂ;Raldh3ﬂ/ﬂ, hereafter named
Raldh1/2/3cKO. When induced by tamoxifen at E10, Raldh1/2/
3cKO mice do not need RA supplementation to survive48.
However, this timing of induction does not permit the analysis
at the brachial level, where RUNX3 expression is observed from
E10.5. Since RUNX3 induction follows the rostral-to-caudal
gradient of normal DRG development, we characterized the
phenotype at lumbar levels, where RUNX3 is ﬁrst observed at
E11.5. Similarly to the rescued Raldh2−/− mice, E13.5 Raldh1/2/
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Fig. 6 Retinoic acid signaling regulates induction of RUNX3 expression in PSNs. a Section of the brachial region of an HHst23 chicken embryo showing
expression of the RA-synthesizing enzyme RALDH2 at the time of physiological induction of RUNX3. Scale bar: 50 μm. b RUNX3 expression is induced in
the presence of RA (500 ng/ml) in a subset of ISL1+ DRG neurons from HHst23 embryos within 12 h of treatment. Scale bar: 50 μm. c Concentration-
dependent response of RA treatment on RUNX3 levels (n= 3). d Immunohistochemistry for ISL1, TRKC and RUNX3 on brachial DRG sections from E11.5
WT and Raldh2−/− mice. Scale bar: 20 μm. e Quantiﬁcation of d, showing no difference in the number of ISL1 or TRKC positive neurons in Raldh2−/− mice
(n= 3, unpaired Student’s t-test). f Quantiﬁcation of RUNX3 expression in TRKC+ neurons of d shows an overall decrease in intensity (*P < 0.05, unpaired
Student’s t-test) and a signiﬁcant F test (F= 0.0009) indicating a larger spreading of the variance between Raldh2+/+ and Raldh2−/− mice (n= 3).
g Quantiﬁcation of TRKC expression in d shows signiﬁcant decrease in its level of intensity per cell in the Raldh2−/− compared to Raldh2+/+ mice (***P <
0.001, unpaired Student’s t-test). h Quantiﬁcation of TRKC+/RUNX3+ DRG neurons on sections from E12.5 Raldh2+/+ and Raldh2−/− mice shows a
twofold decrease in the number of PSNs in the mutants (**P < 0.01, unpaired Student’s t-test, n= 4). i Number of PSNs is also largely decreased at E13.5 in
the Raldh1/2/3cKO (RcKO) mutant mice compared to the control mice Raldh1/2/3 (Cre−/−) (n= 3,*P < 0.05, unpaired Student’s t-test). j Proposed model for
the selection of the TRKC DRG neurons during development, in which neurons, soon after being generated, feature different functional molecular
signatures that are predictive of their survival or death during the cell death period (E12–E12.5). Source data are available as a Source Data ﬁle
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3cKO mutant mice showed a large decrease in the number of
TRKC+/RUNX3+ neurons (47%, Fig. 6i). Altogether, these
results provide evidence that RA signaling in vivo is sufﬁcient
to induce RUNX3 in presumptive PSNs. The observation of some
RUNX3 induction remaining in both mutant models could be
due either to compensatory mechanisms, through activation of
parallel signaling, or most likely, to an incomplete reduction of
RA signaling during the critical period of RUNX3 induction using
our strategies (incomplete efﬁciency of the recombination or of
the clear-out of the RA supplement). Importantly, our results
suggest a model in which the instructive role of RA on PSNs
differentiation might eventually impact their differential capa-
cities to interact with and integrate environmental cues for their
survival (Fig. 6j). It is worth noting that although distinct levels of
trophic factor receptors between neurons might participate in the
ﬁtness characteristic of the cell, other differentially expressed
genes could be contributing to preferential cell survival.
Discussion
The prevailing view explaining cell death mechanisms in the
developing mammalian nervous system is mostly built on the
principle of a one-sided control of cell death by the environment
and a stochastic selection of the surviving neurons. This view has
been supported indirectly by observations that experimental
manipulations of neurons’ environment impact their survival2,3.
Our ﬁndings support an alternative model in which sensory
neurons are endowed with distinct molecular features that are
predictive of their probability to respond to environment-derived
survival signals and thus, to survive the cell death period. We ﬁnd
that prior to cell death, sensory neurons exhibit distinct func-
tional and survival states that are genetically encoded, involve RA
signaling and RUNX3 transcriptional activity. These states are
independent of signals derived from the target tissue and of NT
signaling and eventually lead to the survival selection of a deﬁned
neuronal population. Thus, an early integration of cellular sig-
naling and transcriptional programs driving cell fate decisions are
coupled to a genetically distinct functional and survival ﬁtness
and thus life–death fate outcomes of neurons during competition
for NTs (Fig. 6j).
Past studies on the developmental cell death of neurons in
vertebrates have assumed that all TRK-positive sensory neurons
are initially equivalent and that their individual probability to
survive the competition period is unpredictable4,13,14. The selec-
tive nature of the survival-or-death choice of PSNs during
development that we now reveal contrasts with this principle. Our
results show that two subgroups of PSNs display distinct intrinsic
capacities to compete and thus to survive prior to the cell death
period. Strikingly, our data show that the molecular ﬁtness
characteristics of sensory neurons emerge very early, i.e. soon
after cell cycle exit, and before the selection of nerve trajectories.
Moreover, cell death of sensory neurons is a relatively fast process
(~12 h) and occurs days before the nerve endings contact their
ﬁnal target26. Thus, contrary to the classic competition model, in
which the size of the end organ target ﬁeld would dictate that of
the neuronal population by competition for target-derived
trophic factors, the ﬁnal set of sensory neurons, which is
deﬁned by the cell death program, would determine the number
of peripheral sensory organs being innervated. In this context, a
more selective mechanism of cell death might provide an
advantage to guaranteeing a rapid clearance process of neurons
during early development. The systems matching principle has
been proposed to endow the nervous system with the capacity to
adapt quantitatively to environment changes. It has remained
unclear, however, how neurons are selected during this devel-
opmental period, especially if neurons had equal competitiveness
(stochastic selection) and if the neural network has not fully
developed yet. In our study, the distinct genetic features of the
two neuronal subgroups reveal molecular differences that are
associated with their competitive advantage, and hence deﬁning a
ﬁtness attribute to survive the cell death period. The advantage of
this survival selection process seems to lie within the difference in
the functional state of these two populations of neurons, which
co-varies with the survival advantage status of the cells. Indeed,
the ﬁttest neurons displayed a more mature functional phenotype,
as illustrated by the large representation of genes involved in
neurotransmission in that group. Such proﬁle is consistent with
their acquisition of mature biophysical properties and mechan-
osensitivity during this period, while concomitantly number of
neurons with immature action potentials decreases dramati-
cally40. Interestingly, voltage-gated sodium channels, whose high
density is essential for the generation and propagation of action
potentials, were highly enriched in the ﬁttest neuronal subgroup,
as was Piezo2 which encodes for the major mechanotransduction
channel PIEZO2 in mechanosensitive sensory neurons41,42.
Hence, our data reveal a selection model during nervous system
development where the competitive advantage of a neuron and its
functional state are consubstantial elements of a general ﬁtness
proﬁle that is established by speciﬁc transcriptional programs.
The result of this is the emergence of two distinct subgroups of
neurons, a more ﬁtted and a less ﬁtted, the former out-competing
the latter, which is selectively removed during competition for
survival signals. The mechanisms responsible for the differential
acquisition of these molecular properties by early sensory neurons
remains, however, unclear. Interestingly, those are linked to the
maturation trajectory of PSNs, yet our data show that the timing
of neurogenesis would not contribute signiﬁcantly to these dif-
ferences. Provided that RA is presumably symmetrically dis-
tributed around the ganglion, stochastic process might play a role
in exposing early born neurons to various levels of RA or some
other molecular signaling pathways that would regulate the levels
of RUNX3 and other genes that comprise the two molecularly
distinct clusters of neurons.
Thus, in addition to scaling the ﬁnal number of neurons to
match the size of the targets, cell death in developing sensory
neurons might also participate in scaling their physiological ﬁt-
ness. The genetic distinction of populations of neurons with
various intrinsic molecular settings and ﬁtness observed in our
study could serve as a more general mechanism preceding the
selection step (through cell death), which would eventually favor
the most suitable cells for the establishment of functional neural
networks.
Our study also suggests similarities with the developmental cell
death mechanisms in Caenorhabditis elegans where neuron pre-
cursors feature complex death codes that predict their survival or
death49. A particularity of the development of C. elegans is,
however, its invariant character, with 105 cells from the neuronal
lineage being programmed to die at speciﬁc places and times49,
underlying the importance of lineage programming in this
organism. In this context, it remains to be determined in verte-
brates whether the predisposition of some neurons to survive or
die during development is also lineage dependent or acquired
postmitotically.
Sensory neurons of the trunk derive from neural crest stem
cells which delaminate from the dorsal neural tube, with some
migrating ventrally and settling between the neural tube and the
dermomyotome to generate the DRG50. Later during develop-
ment, these neurons will connect to peripheral organs or tissue
and to speciﬁc neurons in the spinal cord18. In the case of PSNs,
their peripheral projections reach their muscle targets by E14.0,
while their central projections contact MNs in the ventral spinal
cord at about E17.551,52. The establishment of these networks
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occurs several days after the cell death period in the DRG. How
then is the development of each of these spatially disconnected
structures coordinated for quantitative systems matching? These
three structures (MNs, sensory neurons and skeletal muscles)
develop simultaneously from adjacent precursor regions50,53,54.
Hence, the use of a common source of signaling molecules acting
locally could participate in their synchronous development. RA,
which is produced by the paraxial mesoderm44–46,55, has been
shown to control the cellular speciﬁcation and number of limb
muscle cells and MNs54–57. Our results provide evidence that RA
regulates the speciﬁcation of PSNs cell fate, which might impact
their ﬁnal number. Therefore, the paraxial mesoderm, through
RA production, could serve as a signaling center for the coordi-
nated development of sensory neurons, MNs and skeletal muscles
and play an important part in the establishment of a future
functional sensory-motor circuit.
Finally, cell-based therapies for neuronal replacement after cell
loss have great potential for treating neurological disorders58,59.
For this, in vitro culture systems are used to derive speciﬁc
neuron types from stem cells, which are then transplanted locally
to disperse in the targeted neural tissue. A limitation of this
therapeutic strategy is, however, to optimize the survival and the
integration of the transplanted (newly speciﬁed) neurons into
functional networks59,60. Recent studies and ours suggest a het-
erogeneity in newly developed neurons, which affects their ﬁtness
and would eventually impact their survival and functional
integration60,61. Therefore, a better understanding of the distinct
molecular features of individual developing neurons or stem-cell-
derived neurons and their correlation with in vivo cell survival
and function might provide a critical step in ensuring optimal and
reproducible cell preparations for successful transplantation.
Methods
Animals. Wild-type C57BL6 mice were used unless speciﬁed otherwise. Runx3−/−,
TrkCCreER, Raldh2−/−, Raldh1ﬂ/ﬂ, Raldh2ﬂ/ﬂ, Raldh3ﬂ/ﬂ and the CAGGCreERTM
mouse strains have been described elsewhere30,48,62–65. Bax−/−, R26CreERT2,
TrkC−/− and Ai14 mice have been purchased from Jackson Laboratories, and
NT3−/− and TrkCCre from MMRRC. Animals of either sex were included in this
study. Animals were group-housed, with food and water ad libitum, under 12 h
light–dark cycle conditions.
Fertile white Leghorn eggs were incubated at 38 °C and embryos were staged
according to Hamburger–Hamilton (HH) tables.
All animal work was performed in accordance with the national guidelines and
approved by the local ethics committee of Stockholm, Stockholms Norra
djurförsöksetiska nämnd.
Treatments. Rescued RA animals. For the RA-rescue experiments, pregnant
females were treated with RA (all-trans-RA, Sigma) in powdered food between E7
to E9 at a dosage of 100 μg/g of food.
Conditional KO with tamoxifen treatment. Pregnant mothers of CAGGCreEM;
Radh1ﬂox/ﬂox;Raldh2ﬂox/ﬂox;Raldh3ﬂox/ﬂox embryos (referred as Raldh1/2/3cKO)
were administered by gavage a dose of tamoxifen (0.1 mg per g of b.w.; Sigma)
dissolved in corn oil (25 mg/ml).
Cell fate tracing experiments with 4-OHT. R26tdTom mice were crossed to the
TrkCCreER and to R26CreERT2 mice for cell fate tracing of the PSNs and for timing of
early and late born neurons from the ﬁrst wave of neurogenesis in the DRGs. 4-
OHT induction of the TrkCCreER mouse line was performed by single
intraperitoneal injection of either low doses (0.018 g or 0.032 g per kg bw) or higher
doses (0.06 g or 0.08 per kg bw) depending on the hypothesis tested (4-OHT,
Sigma, H6278) into pregnant mothers at the indicated stages. 4-OHT was dissolved
in 99.5% ethanol and further diluted 1:1 in Cremophor® EL (Sigma C5135) to
obtain a concentration of 20 mg/ml for storage at −20 °C. 4-OHT stock solution
was further diluted 1:3 in DPBS to a working concentration of 5 mg/ml upon usage.
Analysis was performed on 2–8 animals from 2–3 separate experiments.
In ovo electroporation. A control plasmid pCAGeGFP and siRNAs were injected
in ovo into the neural tube of HHst13/14 chick embryos (plasmids concentration:
1 µg/µl, siRNA concentration: 0.07 nM, Ambion). Five pulses of 50 V/cm was
performed using a square wave electroporator (BTX). Embryos were collected 3 or
5 days post electroporation and processed for immunostaining.
In vitro cultures of DRG neurons/whole DRGs. Dissociated DRG neurons were
obtained after enzymatic digestion of brachial DRG from E11.5 embryos using
trypsin (0.05% Trypsin–EDTA; Gibco). Cells were plated in 24-well plates pre-
coated with poly-D-lysine (0.01%; Sigma)/laminin (10 μg/ml; R&D Systems). Cells
or whole DRG were cultured in N2 medium (DMEM-F12/glutamax medium with
N2 supplement; Gibco) supplemented with pen/strep, gentamicin and with NT3
(Peprotech) when speciﬁed. For in vitro RUNX3 induction in whole chicken DRGs,
NT3 (10 ng/ml, R&D systems), RA (500 ng/ml, Sigma) and the pan-caspase inhi-
bitor Q-VD-OPh (10 μM, Sigma) were used. For the survival assay using mouse
E11.5 DRG neurons, the majority of neurons die during the ﬁrst 24 h in the
absence of NTs66, and the addition of NT3 promotes selectively the survival of
PSNs67. For transcripts (qPCR) measurements, whole DRGs were cultured in 2-ml
open tubes in closed Petri dishes for the indicated time.
Immunostainings and RNAscope® in situ hybridization. Animals were collected,
decapitated and ﬁxed for 1–4 h at +4 °C (4% PFA in PBS) depending on the stage,
washed in PBS, cryopreserved in 30% sucrose in PBS, embedded in OCT (Tissue-
Tek) and cryosectioned at 14 μm. In situ hybridization was performed using
standard RNAscope protocol (ACDBio). The RNAscope probes used in this study
are Mm-Fyxd7 and Mm-Pou2f2 (ACDBio). Dissociated cultures were ﬁxed for
5–20 min in cold PFA (4% in PBS). Sections or dissociated cultures were incubated
for 24 h at +4 °C with primary antibodies diluted in blocking solution (2% donkey
serum, 0.0125% NaN3, 0.5% Triton X-100 in PBS). Primary antibodies used were:
rabbit anti-RUNX3 (gift from Jessell TM), goat anti-TRKA (1:400, R&D Systems
AF1056), goat anti-TRKB (1:500, R&D Systems AF1494), rabbit anti-TRKC
(1:1000, Cell Signaling 3376), mouse anti-ISL1 (1:250, Developmental Studies
Hybridoma Bank 39.4D5), goat anti-RET (1:100, R&D Systems AF482), goat anti-
TRKC (1:500, R&D Systems AF1404), mouse anti-βIII-tubulin (1:1000, Promega
G712A), rabbit anti-pAKT (1:100, Cell Signaling 4060S), chicken anti-RFP (1:250,
Rockland 600-901-379S). After washing with PBS, Alexa Fluor secondary anti-
bodies (Live Technology; 1:500 in blocking solution) were applied overnight (at +4
°C). Phalloidin conjugated with Alexa 488 was purchased from Life Technology.
Samples were then washed in PBS and mounted in DAKO ﬂuorescent mounting
medium. Staining was documented by confocal microscopy (Zeiss LSM700) using
identical settings between control and experimental images. Optical sections were
2 μm in 20× overview pictures unless speciﬁed.
Quantiﬁcations. For neuronal counting, soma area and intensity quantiﬁcations
ImageJ software was used. Only neurons with a visible nucleus were used. Quan-
tiﬁcation of molecular markers in the dorsa root ganglia was carried out on a
minimum of ﬁve DRGs sections or more randomly selected sections per animal,
per condition (see ﬁgure legends for n’s and genotypes). In Fig. 1a, for accurate
quantiﬁcation and comparison of the number of PSNs across stages, we quantiﬁed
the total number of PSNs in every third sections of C5 and C7 DRGs. Also, note
that for the βIII-tubulin quantiﬁcation, the two outer lateral rows of cells in the
different DRGs sections were not included in the analysis due to saturation of
signal caused by axonal track passage that are heavily stained.
Cell intensity quantiﬁcation. Quantiﬁcation of the intensity of protein of interest
from DRG sections from mice was carried out by manually drawing the cell area of
interest (deﬁning the regions of interest (ROIs)); soma, nuclei and growth cone
depending on the experiment. To deﬁne RUNX3 intensity in the RUNX3+/TRKC+
neuron, for a given RUNX3+/TRKC+ cell (exp_cell), the raw integrated density of
a RUNX3−/TRKC− cell (control_cell) (representing the background intensity),
normalized to its area was subtracted from the raw integrated density of the
RUNX3-positive cell (exp_cell), normalized to its area, as follows: RUNX3 intensity
(exp_cell)= [RawIntDensity (exp_cell) / Area (exp_cell)] – average [RawIntDensity
(control_cell) / Area (control_cell)]. Reads were averaged by section and plotted by
genotype.
Statistics. Data were analyzed using GraphPad Prism 5 and expressed as mean ± S.
E.M., except for dot plots showing S.D. The statistical test performed is reported in
the ﬁgure legend; t tests were two-sided. Legend for signiﬁcance: *P ≤ 0.05, **P ≤
0.01, ***P ≤ 0.001. Data distribution was assumed to be normal. No animals or data
points were excluded from the analyses. No statistical methods were used to pre-
determine sample size but our sample sizes are similar to those generally employed
in the ﬁeld. Note also that each measurement was taken from distinct samples.
qPCR. Brachial level DRGs were dissected from six E11.5 embryos. DRGs were
arranged so that each biological replicate contained ﬁve DRG (C4–C8) from one
embryo, and the same from another embryo. Experimental conditions were
Zero (DRG placed directly into lysis buffer after dissection), and +NT3/−NT3
(DRG cultured in for 6 h in with or without recombinant human NT3
(Peprotech, cat. no. 450-03). DRG were cultured in DMEM:F12 (Gibco) + 10%
FBS (Gibco) supplemented with 5 µM of caspase inhibitor Q-VD-OPh (Cal-
biochem, cat. no. 551476) in 2-ml tubes. After either dissection (Zero) or culture
(+NT3/−NT3), RNA was extracted using the Qiagen RNeasy Mini Kit
according to the manufacturer’s instructions, including DNase I to degrade
potential genomic DNA contamination. RNA quality was quantiﬁed using the
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Biorad Experion Standard Sensitivity RNA Kit, which showed the RNA had
RINs between 9.7 and 10. RNA was quantiﬁed using the Qubit RNA BR Assay
Kit, and 50 ng of each biological replicate used for reverse transcription using
Biorad iScript in a 20-µl reaction according to manufacturer’s instructions. No
reverse transcriptase controls were carried out at the same time by substituting
water for the reverse transcriptase. Resulting cDNAs were used to analyze
transcript levels using real-time PCR in a Biorad CFX96 Real-time System and
using Biorad iTaq Universal SYBR® Green Supermix in 20-µl reactions for 40
cycles (95 °C 10 s, 60 °C 20 s, 72 °C 30 s followed by ﬂuorescence measurement
at 75 °C to reduce the inﬂuence of primer dimer on quantiﬁcation). Primers
used (5′and 3′): B2m, GGT CGC TTC AGT CGT CAG and TC AGT ATG TTC
GGC TTC CC; Etv1, TAC AAG AAA CAT GGC TTG CTG AAG and CAT
GAA AAG CCA AAC TTT CAG CCT; Gapdh, AAC TCC CAC TCT TCC ACC
TTC and GAT AGG GCC TCT CTT GCT CAG; Hprt, GAA TCT GCA AAT
ACG AGG AGT CCT and CTT TAC TAG GCA GAT GGC CAC A; Mapk6,
TGT TGT GCA CGA GGA GGA TC and TGT GTG GCT CAG TCA TGT CG,
Ntrk3 PAN, AGT AAC CGG CTC ACC ACA CTC and AGC GGA TGT CAC
AGC TGC AGT; Ntrk3 FL, TGA TCC TCG TGG ATG GAC AG and CTT CAC
TAG TAG ATT GGC TCC. Mapk6 and Gapdh were included as reference genes.
No template and no reverse transcriptase controls did not amplify, or were
detected at least ﬁve cycles after the least strong biological sample. In addition,
amplicons were sequenced to conﬁrm speciﬁcity. Data were analyzed using
qBase+ (Biogazelle, Belgium).
The truncated isoforms of Ntrk3 cannot be uniquely measured by qPCR
method. Hence, the quantity of Ntrk3 T transcripts is deduced by subtracting the
value of Ntrk3 FL from the value of pan Ntrk3.
smFISH. Ten-micrometer-thick sections were mounted on cover glasses. Fresh
sections selected for the experiment were post-ﬁxed with 4% PFA (in PBS) for
10 min at room temperature, rinsed with PBS and permeabilized with methanol.
After permeabilization, the sections were incubated for 10 min at 70 °C in Tris-
EDTA pH 8.0. After washing twice with SSC 2×, the sections were incubated with
hybridization buffer containing 250 nM ﬂuorescent label probes (LGC Biosearch
Technologies; see Supplementary Table 1) for 4 h at 38.5 °C. After four 20%
formamide-SSC 2× washes, the slides were counterstained with Hoechst, washed
with SSC 2× and mounted with Prolong Gold mounting medium (ThermoFisher
Scientiﬁc). Image stacks (0.3 µm distance) were acquired using a Nikon Ti-E with
motorized stage (Nikon).
The images were analyzed with a custom python script using the numpy, scipy.
ndimage (http://www.scipy.org/) and scikit-image libraries68. Brieﬂy, after
background removal using a large kernel Gaussian ﬁlter, a Laplacian-of-Gaussian
was used to enhance the RNA dots in the maximum projected image. Background
objects signiﬁcantly larger than the smFISH dots were removed after image
thresholding and the remaining RNA dots counted in user-deﬁned ROIs. The
images were stitched, aligned and pseudocolored in Fiji. Pseudocolored images
were generated by mapping the number of RNA molecules counted in each ROI to
the value of a HSV color scale. For each image, a color value of zero corresponds to
zero RNA molecules and the maximum color value is used to represent the highest
molecular count.
Arlecchino image: after manual segmentation of the cells, the signal intensity
was measured using imageJ. The signal intensity was binned in six expression
classes and each class was identiﬁed with a different hue. The green color
represents the lowest expression level and cyan the highest.
The truncated isoforms of Ntrk3 cannot be uniquely labeled using the smFISH
method. Hence, the number of Ntrk3 T molecules in Supplementary Fig. 4a, b is
deduced by subtracting, in individual cells, the number of Ntrk3 FL from the
number of pan Ntrk3.
Single-cell isolation for single-cell analyses. Brachial DRGs were dissected and
collected in Leibovit’z L-15 medium (Life technologies) on ice. Then the DRGs
were incubated in 0.05% trypsin-EDTA (1×) (Life technologies) for 5, 7, 10 and 15
min for DRGs from E9.5, E10.5, E11.5 and E12.5, respectively, at 37 °C, in a
thermomixer comfort (Eppendorf) at 700 RPM. After spinning down the samples
at 100 RCF for 5 min, the supernatant was removed and replaced by Leibovit’z L-15
medium (Life technologies). DRGs were physically triturated using two different
sizes of pipettes previously coated with 0.2% bovine serum albumin until the
solution homogenized. The cell suspension was then ﬁltered through a 70-μm cell
strainer (BD Biosciences) to remove the clusters of cells.
Fluorescence-activated cell sorting (FACS). Single Tomato-positive cells were
sorted by FACS into individual wells of 384-well plates containing lysis buffer. The
plates containing single cells were frozen immediately on dry ice and stored at
−80 °C. We used six animals (ten DRGs per animal) per experiment.
Single-cell RNA sequencing.
● Smart-Seq2 protocol was performed on single isolated cells by Eukaryotic
Single Cell Genomics Facility at SciLifeLab, Stockholm69. Raw data
processing:
the raw data of single-cell RNA sequencing was processed with standard
pipeline by Eukaryotic Single Cell Genomics Facility at SciLifeLab,
Stockholm. Most of the downstream analysis was done using R software
package Seurat v2.0.
● Pre-processing (Initial ﬁltration, normalization):
In our initial analysis of the data, we noticed contamination of non-
sensory neurons in each dataset. But sensory neurons could be easily
distinguished by their high expression of Pou4f1. Thus, we only selected
cells with Pou4f1 transcript count over 5 for further analysis.
Considering the distribution of genes identiﬁed in every cell, we selected
cells with at least 4000 unique genes detected for downstream analysis. This
step removed empty wells and low-quality cells. Genes expressed in less
than three cells were also removed from analysis.
We used a global normalization strategy incorporated in SEURAT
package to make the data comparable between different cells and between
different SMART-seq2 runs. The gene expression measurements within
each cell were scaled by a constant factor 10,000, then natural-log
transformed. This generated a new gene expression matrix yi,j= log (xi,j/
Zj × 10,000), where xi,j is the count of gene i in cell j and Zj is the total
counts of all genes in cell j.
We calculated the dispersion (ratio of variation to mean) of genes,
excluding those lowly expressed on average (normalized value <0.0125) or
less variable (variation <0.5). The remaining 4008 variable genes were used
for dimensional reduction. We also regressed out the cell–cell variation in
gene expression driven by percent.mito (the percentage of mitochondrial
gene content) using ScaleData function.
● Linear dimensional reduction:
We used principal component analysis (PCA) to reduce the dimension-
ality of the data. Twenty PCs were computed and ﬁrst 15 PCs were
determined as statistically signiﬁcant through the JackStraw method. We
then applied t-SNE to visualize the data in a two-dimensional space.
● Identify differentially expressed genes:
To identify differentially expressed genes in each cluster, we used
likelihood-ratio test implemented in function FindMarkers. The parameters
min.pct= 0.25 and thresh.use= 0.1 are chosen to select genes expressed in
more than 25% of cells and with average expression level over 0.1
(normalized data) in the given cluster. The genes were ranked by P-value
from low to high, with lower P-value indicating more differentially
expressed genes.
● Boxplots: For boxplots shown in Supplementary Fig. 8, the lower and upper
hinges represent the ﬁrst and third quartiles, respectively, so the box spans
the inter-quartile range (IQR). The horizontal line inside the box
corresponds to median. The upper whiskers extend to the largest value no
further than 1.5 × IQR from the upper hinge, while the lower whiskers
extend to the smallest value at most 1.5 × IQR from the lower hinge. Dots
represent the outliers beyond the range of whiskers.
Gene Set Enrichment Analysis visualized by network. All differentially
expressed genes in Runx3High and Runx3Low population were used as input for
Gene Set Enrichment Analysis (GSEA) using Cytoscape and its plugin Bingo. The
most up-to-date gene ontology ﬁle go-basic.obo and gene association ﬁle gen-
e_association.mgi were downloaded directly from Gene Ontology Consortium
website instead of using Bingo’s default ontologies or associations, which is not
updated frequently. The following evidence codes were discarded from analysis:
IEA (inferred from electronic annotation), ISS (inferred from sequence similarity).
Signiﬁcant GO terms (P-value < 0.05) were used as input for Cytoscape’s plugin
EnrichmentMap to generate a network where mutually overlapping gene sets
cluster together. Following parameters were used: P-value cutoff 0.001, FDR Q-
value cutoff 0.05, similarity cutoff with Jaccard coefﬁcient 0.25.
RNA velocity. We performed a pre-analysis that included the entirety of cells
obtained by our sorting strategy; the aim was to isolate the Runx3+/Ntrk3+
population in an unbiased fashion. This choice was motivated by our intention to
avoid explicit ﬁltering based on the expression of those genes, a procedure that
could have excluded part of the cells of interest (because of sequencing drop-out
events) or included unrelated cells (because of cross-contamination events).
As a ﬁrst preprocessing step, we excluded cells with <150,000 total reads counts
and red blood cells, these were easily recognized by their low number of detected
genes or the extremely high hemoglobin read counts. Furthermore, we removed genes
that were not reliably detected, our condition for retention was: a gene needs to have
at least 38 read counts across the whole dataset and at 18 counts in at least one cell. To
select the most informative genes for downstream analysis, we applied a feature
selection procedure70. Brieﬂy, a noise model was ﬁt on the data and genes are ranked
by the residuals to the ﬁt, the top 1400 genes were selected. We log-transformed the
data matrix and we generated a 20 nearest-neighbors graph using Euclidean distance
in the space spanned by the ﬁrst six principal components. This graph was, then,
imputed to the Louvain community detection algorithm to cluster the cells.
For the core analysis on the Runx3+/Ntrk3+ populations (n= 274), we used a QC
and ﬁltering procedures that identical to the one described above with the following
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differences: that we selected more genes (1900 genes), more PCA components (65)
and 25 nearest neighbors to construct the graph and perform Louvain clustering.
These choices were aimed at extracting the most accurate representation of the
dataset. To visualize the data, we used UMAP with parameters n_neighbors= 40,
learning_rate= 0.6, min_dist= 0.5 and spread= 0.55. RNA velocity analysis was
then performed using our tool velocyto.py43. We used the default parameters that we
used in the original publication43 with three differences:
● We pre-processed the data matrix only minimally (since the data is deeply
sequenced and high quality), by calling velocyto.knn_imputation with
parameters k= 5, b_sight= 50 and b_maxl= 20
● Only the most mature cell population (Cluster 3 in Fig. 5h) consisting entirely
of cells sampled at the time point E12.5 was used to ﬁt the degradation rate
parameter (i.e. gamma). This procedure corresponds to the assumption that
these cells are less rapidly changing and closer to a steady state.
● We adapted the parameter analysis to the number of cells in this dataset, in
particular the estimate_transition_prob function was passed the arguments
n_neighbours= 90 and calculate_grid_arrows the arguments smooth= 0.4,
steps= (20, 20), n_neighbors= 40.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The accession number for the data used in this article is GEO: GSE135181. Data that
support the ﬁndings of this study are also available from the corresponding authors upon
reasonable request. Source data underlying Figs. 1–6 and Supplementary Figs. 2–7 are
available as a Source Data ﬁle.
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